Navigation Links
Engineered Tissue Implants benefited Knee Injured patients
Post Your Comments:
(Date:11/21/2009)...al apparel company launches men,s lab coats at Med... Clemente, Calif. (PRWEB) November 21, 2009 -- Med... today announced the launch of its men,s lab coats...nternational trade fair for the medical industry h...ts men,s collection with three varying lab coat st...
(Date:11/21/2009)... Group merges their practice with that of E. Steve... (PRWEB) November 21, 2009 -- The New Ha...Gibson, Dr. Dean Cloutier, Dr. John Plachtyna and ... practice with that of esteemed colleague Dr. E. S...ted to retire from dentistry in order to concentra...
(Date:11/20/2009)...wire-FirstCall/ - NUCRYST Pharmaceuticals Corp. an...rs will be held on Monday, December 21, 2009. The ...two special resolutions. The first special resolut... substantially all of the assets of NUCRYST, subst...rchase agreement dated November 10, 2009 among the...
(Date:11/20/2009)...ire/ -- Following a recall by Unilever The Stop &a...dd,s Country Crock ® Side Dishes DELUXE Chedd...Side Dishes DELUXE Four Cheese Pasta due to an und...e dates and UPCs are affected: ,, Shedd,s Coun...li Rice 21 oz, UPC 027400218316, Best By NOV 29 09...
(Date:11/20/2009)...Newswire/ -- The American Dental Association (ADA)... (FDA) to establish appropriate classifications fo... about the safety of whitening products that are o...nal consultation or examination by a dentist, the ...y based tooth whitening or bleaching agents can ha...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...national (EMI) has just named its Elite Meetings A...steemed experts from both the event planning and t...iews destination hotels and resorts worldwide for ...te Meetings International (EMI) has just named its...
...ent and Patient,Safety Institute (RM&PSI), a n...es and patient safety programs for health care ins...ear license partnership with Salus Global,Corporat...ch was effective January 1, 2009, RM&PSI becom...
...es all foods to help consumers take charge of heal...eadership and social attitudes herald a new era of... nutrition experts are urging consumers to take in...ir diets and overall health, they often are left c...
...treatment earlier , , MALVERN, Pa. and Abbott Pa... Abbott have signed a license agreement to develop...omated ARCHITECT(R) diagnostic analyzers. Under th...tion of women at high risk for ovarian cancer, a d...
...ffers Advice and Opinions - , , WASHINGTON, Jan. ...ding sources of news analysis and service journali...alth channel offerings to include an interactive m...Health Editor Dr. Bernadine Healy, former head of ...
...d: NTRZ), a world leader in stabilized rice bran (...oday it has teamed up with FedEx Corp. (NYSE: FD...plement made with NutraCea,s stabilized rice bran ...tely 57,000 units of their nutritional food supple...
Other Medicine News:Health News:Elite Meetings International Names New Advisory Board 2Health News:Elite Meetings International Names New Advisory Board 3Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 2Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 3Health News:The Risk Management and Patient Safety Institute Announces Exclusive Partnership with Salus Global Corporation to Launch MORE(OB) to U.S. Market 4Health News:First U.S. Supermarkets Launch Total Nutrition Scoring System 2Health News:First U.S. Supermarkets Launch Total Nutrition Scoring System 3Health News:First U.S. Supermarkets Launch Total Nutrition Scoring System 4Health News:First U.S. Supermarkets Launch Total Nutrition Scoring System 5Health News:Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers 2Health News:Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers 3Health News:U.S. News Media Group Expands Online Health Channel with Interactive Medical Expert Forum 2Health News:U.S. News Media Group Expands Online Health Channel with Interactive Medical Expert Forum 3Health News:NutraCea, FedEx and Feed The Children Team Up to Provide Food Aid to Families in Need in Brazil 2Health News:NutraCea, FedEx and Feed The Children Team Up to Provide Food Aid to Families in Need in Brazil 3Health News:NutraCea, FedEx and Feed The Children Team Up to Provide Food Aid to Families in Need in Brazil 4
(Date:11/20/2009).... 20 Cyberonics, Inc. (N...sident and Chief Executive Officer, and Greg Brown...st Annual Piper Jaffray Health Care Conference in ...M EST. The conference session and webcast will be.... Piper Jaffray will host a webcast of the presen...
(Date:11/20/2009)...J., Nov. 20 Soligenix, I...ompany), formerly known as DOR BioPharma, Inc., a ...that it has formed a consortium to develop thermos...pidly acting vaccines. Soligenix received a $9.4 m...y and Infectious Diseases (NIAID), a division of t...
(Date:11/19/2009)...o., Nov. 19 In a series ...ience, Heska Corporation (Nasdaq: HSKA ) ("Heska"...ts new and improved website. The upgraded site is...and programming to align the site with the company..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 1Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 2Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 3Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 4Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 5Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 6Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 7Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 8Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 9Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 10Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 11Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 12Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 13Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 14Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 15Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 16Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 17Narconon Trois Rivieres Cites Hillbilly Heroin as Canadian Drug Addiction Crisis 52510 1Narconon Trois Rivieres Cites Hillbilly Heroin as Canadian Drug Addiction Crisis 52510 2Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 1Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 2Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 3
...e SNS-595 to Next Stage of Phase 2 Trial Achieved,...OR RELEASE AT 3:30 P.M. EDT, TODAY/ -- Sunesis Pha...age biopharmaceutical company developing novel,ant...liminary results from,the first stage of the compa...oduct candidate, SNS-595, in platinum-resistant ov...
...WASHINGTON, Oct. 23 Boston,Scientific Corporation...,results from its CABERNET and BEACH carotid arter...the effectiveness of stenting with embolic,protect...ectomy (CEA), the,surgical treatment for carotid a...esults were presented by L. Nelson Hopkins, M.D., ...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 2Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 3Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 4Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 5Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 2Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 3Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 4Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 5
Bledsoe Extender Knee Brace
Bledsoe Post-Op Knee Brace
Bledsoe Basic Knee Brace
Extensor™ Patellar Knee Support with Lateral Strap
Medicine Products: